EcoDrugPlus

Erb-B2 Receptor Tyrosine Kinase 2

Ensembl ID : ENSORLG00000005702
Gene Symbol: ERBB2
4 Cross references
200 Possible Orthologues:

Erb-B2 Receptor Tyrosine Kinase 3a

Ensembl ID : ENSORLG00000001520
Gene Symbol: ERBB3A
3 Cross references
211 Possible Orthologues:

Erb-B2 Receptor Tyrosine Kinase 3b

Ensembl ID : ENSORLG00000007685
Gene Symbol: ERBB3B
4 Cross references
206 Possible Orthologues:

Erb-B2 Receptor Tyrosine Kinase 4

Ensembl ID : ENSORLG00000016023
Gene Symbol: ERBB4
4 Cross references
47 Possible Orthologues:

Estrogen Receptor 1

Ensembl ID : ENSORLG00000014514
Gene Symbol: ESR1
4 Cross references
215 Possible Orthologues:

Estrogen Receptor 2a

Ensembl ID : ENSORLG00000017721
Gene Symbol: ESR2A
3 Cross references
198 Possible Orthologues:

Estrogen Receptor 2b

Ensembl ID : ENSORLG00000018012
Gene Symbol: ESR2B
3 Cross references
208 Possible Orthologues:

Estrogen-Related Receptor Gamma A

Ensembl ID : ENSORLG00000011528
Gene Symbol: ESRRGA
3 Cross references
198 Possible Orthologues:

Exportin 1

Ensembl ID : ENSORLG00000001642
Gene Symbol: XPO1
4 Cross references
213 Possible Orthologues:

Exportin 1

Ensembl ID : ENSORLG00000001559
Gene Symbol: XPO1
4 Cross references
224 Possible Orthologues:

Farnesyl Diphosphate Synthase (Farnesyl Pyrophosphate Synthetase, Dimethylallyltranstransferase, Geranyltranstransferase)

Ensembl ID : ENSORLG00000010041
Gene Symbol: FDPS
4 Cross references
267 Possible Orthologues:

Farnesyl-Diphosphate Farnesyltransferase 1

Ensembl ID : ENSORLG00000017362
Gene Symbol: FDFT1
4 Cross references
220 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).